| Not Yet Recruiting | A Phase 3 Clinical Study of QL2106 Injection Plaque Psoriasis | Phase 3 | 2026-06-15 |
| Not Yet Recruiting | QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) Heterozygous Familial Hypercholesterolemia (HeFH) | Phase 3 | 2026-05-01 |
| Not Yet Recruiting | QLS5212 for Participants With Advanced Solid Tumors Solid Tumor Cancer | Phase 1 | 2026-04-30 |
| Not Yet Recruiting | Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients Thrombocytopenia, Immune | Phase 3 | 2026-04-20 |
| Not Yet Recruiting | A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis Moderate-to-severe Atopic Dermatitis | Phase 2 | 2026-04-05 |
| Not Yet Recruiting | QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma (ESCC) | Phase 3 | 2026-04-05 |
| Not Yet Recruiting | QLS5132 Combination Therapy in Advanced Solid Tumors Gastric Cancer (GC), Non-small Cell Lung Cancer (NSCLC), Endometrial Cancer | Phase 1 / Phase 2 | 2026-04-01 |
| Not Yet Recruiting | QLS1410 in Participants With Uncontrolled Hypertension Hypertension (HTN) | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa Adults With Moderate-to-severe Hidradenitis Suppurativa | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Efficacy and Safety of QLG1090 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2026-04-01 |
| Not Yet Recruiting | Study of QLS5308 in Patients With Advanced Solid Tumors Metastatic Solid Tumors | Phase 1 | 2026-03-28 |
| Not Yet Recruiting | QLS12010 in Participants With Moderate-to-severe Rheumatoid Arthritis Rheumatoid Arthritis (RA) | Phase 2 | 2026-03-05 |
| Not Yet Recruiting | QLC7401 Monotherapy in Non-familial Hypercholesterolemia or Mixed Dyslipidemia Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | 2026-03-05 |
| Not Yet Recruiting | A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration Neovascular Age-Related Macular Degeneration (nAMD) | Phase 3 | 2026-03-01 |
| Not Yet Recruiting | A Study of QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI) | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lip Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 3 | 2026-03-01 |
| Not Yet Recruiting | A Study to Compare the PK , Safety, and Immunogenicity of QL2109 With Daratumumab in Male Subjects Multiple Myeloma | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | A Food Effect Study of QLS1410 in Healthy Chinese Adults Uncontrolled Hypertension | Phase 1 | 2026-01-23 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Meropenem and Pralurbactam in HABP/VABP Hospital-acquired Bacterial Pneumonia and Ventilator-associated Bacterial Pneumonia | Phase 3 | 2026-01-22 |
| Recruiting | Phase Ib/II Clinical Study of QLS1304 Combined With Endocrine Therapy in the Treatment of ER+/HER2- Breast Can Advanced ER+/HER2- Breast Cancer | Phase 1 / Phase 2 | 2026-01-05 |
| Not Yet Recruiting | A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies Relapsed/Refractory Hematological Malignancies | Phase 1 | 2026-01-01 |
| Not Yet Recruiting | A Phase I Trial of Subcutaneous QLS7305 in Healthy Adults Healthy Volunteers - Male and Female | Phase 1 | 2026-01-01 |
| Not Yet Recruiting | First in Human Study of QLS5316 in Solid Tumors Solid Tumors, Colorectal Cancer, Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | Phase 1 | 2026-01-01 |
| Not Yet Recruiting | A Study of Romiplostim N01 Plus IST vs. Placebo Plus IST for Treatment-Naive Severe Aplastic Anemia Treatment-naïve Severe Aplastic Anemia | Phase 3 | 2026-01-01 |
| Not Yet Recruiting | Safety, Tolerability, PK, PD, and Immunogenicity of QL2401 in Healthy Chinese Adults Metabolic Dysfunction-Associated Steatohepatitis(MASH) | Phase 1 | 2026-01-01 |
| Not Yet Recruiting | A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subject Anaemia | Phase 3 | 2025-12-31 |
| Not Yet Recruiting | Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Met Metastatic Solid Tumors | Phase 1 / Phase 2 | 2025-12-30 |
| Not Yet Recruiting | Compare the Efficacy and Safety of QL2302 Versus Tezspire® in Severe Asthma Asthma | Phase 3 | 2025-12-25 |
| Not Yet Recruiting | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subj Healthy Participants | Phase 1 | 2025-12-22 |
| Recruiting | A Phase I Study of QLS2309 Injection in Patients With CD70+ Relapsed/Refractory Hematologic Malignancies Relapsed or Refractory Hematologic Malignancies | Phase 1 | 2025-12-05 |
| Active Not Recruiting | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2106 vs Tremfye® in Healthy Subjec Healthy Participants | Phase 1 | 2025-11-10 |
| Recruiting | A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd Relapsed or Refractory Multiple Myeloma | Phase 3 | 2025-11-07 |
| Recruiting | A Study of QLC5508 Combinations in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 / Phase 2 | 2025-10-24 |
| Not Yet Recruiting | Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer Prostatic Neoplasms | Phase 1 / Phase 2 | 2025-10-01 |
| Not Yet Recruiting | A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Ad Advanced Prostate Cancer | Phase 1 / Phase 2 | 2025-10-01 |
| Recruiting | Assess the Plasma, Epithelial Lining, and Alveolar Macrophage Concentrations of Intravenous Meropenem-Pralubac Infections | Phase 1 | 2025-09-13 |
| Recruiting | Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma Relapsed or Refractory Multiple Myeloma | Phase 2 | 2025-09-12 |
| Recruiting | A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Can Pancreatic Cancer | Phase 3 | 2025-09-08 |
| Recruiting | A Phase III Study of ESG401 for Unresectable Recurrent or Metastatic Triple-Negative Breast Cancer Triple-Negative Breast Cancer (TNBC) | Phase 3 | 2025-09-04 |
| Not Yet Recruiting | A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension Uncontrolled Hypertension | Phase 1 | 2025-09-01 |
| Not Yet Recruiting | Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of Non-Small Cell Lung Cancer (NSCLC) Carcinoma, Non-Small-Cell Lung | Phase 3 | 2025-09-01 |
| Not Yet Recruiting | A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer Advanced Breast Cancer | Phase 1 / Phase 2 | 2025-09-01 |
| Not Yet Recruiting | Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Ca CLDN18.2-positive Advanced Biliary Tract Cancer | Phase 2 | 2025-09-01 |
| Recruiting | GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients Wi Chemotherapy-induced Peripheral Neuropathy (CIPN) | Phase 3 | 2025-08-01 |
| Not Yet Recruiting | QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of U Metastatic Colorectal Cancer | Phase 3 | 2025-07-01 |
| Not Yet Recruiting | Pharmacokinetics and Pharmacodynamics Study Primary Hypercholesterolemia or Combined Hyperlipidemia Characterized by Elevated LDL-C | Phase 1 | 2025-07-01 |
| Not Yet Recruiting | A Study of QLS5133 Monotherapy in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2025-07-01 |
| Recruiting | A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® Postmenopausal Women With Osteoporosis at High Risk of Fracture | Phase 3 | 2025-06-27 |
| Recruiting | To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients Wi Transthyretin Amyloid Polyneuropathy | Phase 4 | 2025-06-19 |
| Recruiting | A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Small Cell Lung Cancer Extensive Stage | Phase 3 | 2025-06-04 |
| Not Yet Recruiting | The Food Effect on Pharmacokinetics Study of QLC1101 in Healthy Subjects Effect of Food | Phase 1 | 2025-06-01 |
| Not Yet Recruiting | To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Wo Postmenopausal Women With Osteoporosis | Phase 3 | 2025-06-01 |
| Not Yet Recruiting | A Phase Ib Study of QLS4131 in Subjects With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 1 | 2025-06-01 |
| Not Yet Recruiting | Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Local Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2025-06-01 |
| Not Yet Recruiting | A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of QLC1101 in Combination With Other Thera Solid Tumor | Phase 1 / Phase 2 | 2025-06-01 |
| Recruiting | Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis Atopic Dermatitis | Phase 3 | 2025-05-16 |
| Recruiting | A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients Advanced Solid Tumor | Phase 1 / Phase 2 | 2025-05-09 |
| Not Yet Recruiting | Study on the Efficacy and Safety of QLM1016 in Schizophrenia Schizophrenia | Phase 3 | 2025-05-01 |
| Not Yet Recruiting | Phase 1 Clinical Study of QLS5132 Monotherapy in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-05-01 |
| Recruiting | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in Carbapenem-Resistant Enterobacteriace Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI) | Phase 3 | 2025-04-12 |
| Active Not Recruiting | Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers Infertility, Female | Phase 1 | 2025-04-06 |
| Not Yet Recruiting | A Study of QLS1209 in theTreatment of Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2025-04-01 |
| Not Yet Recruiting | A Phase Ⅲ Comparative Study of QL2108 to Dupixent® Atopic Dermatitis | Phase 3 | 2025-04-01 |
| Recruiting | Phase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors Advanced Malignant Tumor | Phase 1 | 2025-03-06 |
| Not Yet Recruiting | QL1706 in Combination With Neoadjuvant Chemotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced, Rese Resectable Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | 2025-03-01 |
| Not Yet Recruiting | Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Ch Primary Hypercholesterolemia or Mixed Hyperlipidemia | Phase 2 | 2025-02-01 |
| Not Yet Recruiting | Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer Prostate Cancer | Phase 3 | 2025-02-01 |
| Not Yet Recruiting | a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy. Small-cell Lung Cancer | Phase 3 | 2025-02-01 |
| Recruiting | A Study to Evaluate Efficacy, and Safety of QL2107 Plus Chemo and Compare With Keytruda in Participants With I NSCLC | Phase 3 | 2025-01-15 |
| Completed | To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting Afte Chemotherapy-Induced Nausea and Vomiting | Phase 3 | 2025-01-03 |
| Not Yet Recruiting | To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma Multiple Myeloma | Phase 3 | 2025-01-01 |
| Recruiting | A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer Colon Cancer | Phase 3 | 2024-12-12 |
| Not Yet Recruiting | Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib NSCLC | — | 2024-12-01 |
| Not Yet Recruiting | A Study of Olanzapine-Samidorphan Tablets in Adults With Schizophrenia Schizophrenia | Phase 3 | 2024-11-01 |
| Not Yet Recruiting | Study to Assess the Efficacy and Safety of Meropenem and Pralurbactam in CIAI Intra-abdominal Infections | Phase 3 | 2024-10-31 |
| Recruiting | QL0911 for the Treatment of Cancer Treatment-Induced Thrombocytopenia Cancer Treatment-Induced Thrombocytopenia | Phase 2 / Phase 3 | 2024-10-22 |
| Recruiting | Compare the Efficacy and Safety of QL0605 Injections at Different Timepoints Chemotherapy-Induced Febrile Neutropenia | Phase 4 | 2024-09-19 |
| Completed | A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® Atopic Dermatitis | Phase 1 | 2024-08-31 |
| Not Yet Recruiting | A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma | Phase 1 | 2024-08-30 |
| Recruiting | A Phase III Study of ESG401 for Locally Advanced or Metastatic HR+/HER2- Breast Cancer Metastatic Breast Cancer | Phase 3 | 2024-07-11 |
| Not Yet Recruiting | Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors Advanced Solid Tumor | Phase 2 | 2024-06-30 |
| Completed | A Study to Compare the Pharmacokinetics and Safety of QL1101 and EU-Avastin® in Healthy Volunteers Tumor | Phase 1 | 2024-06-20 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safety of QLF31907 Combination Therapy in Patients With Advanced Malignan Advanced Malignant Neoplasm | Phase 1 / Phase 2 | 2024-06-15 |
| Recruiting | A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors Non-small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer | Phase 1 | 2024-04-25 |
| Recruiting | A Study Comparing Pharmacokinetic and Safety of QL2109 and DARZALEX FASPRO® in Healthy Adults Tumor | Phase 1 | 2024-04-12 |
| Recruiting | A Study of CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 2 | 2024-03-19 |
| Recruiting | Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Heavy Menstrual Bleeding, Uterine Fibroids | Phase 3 | 2024-01-15 |
| Recruiting | A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis Lupus Nephritis | Phase 3 | 2023-12-25 |
| Unknown | A Study Comparing Pharmacokinetic and Safety of QL2107 and Keytruda® (Marketed in China and the United States) Tumor | Phase 1 | 2023-12-12 |
| Completed | A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis Atopic Dermatitis | Phase 2 | 2023-11-13 |
| Unknown | A Study of QL1706H in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-10-01 |
| Unknown | A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2023-10-01 |
| Not Yet Recruiting | A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2023-09-01 |
| Unknown | Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer Prostate Cancer | Phase 1 | 2023-08-31 |
| Recruiting | A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children Myopia | Phase 3 | 2023-08-20 |
| Unknown | A Study of QLF3108 in Participants With Advanced Solid Tumor Advanced Solid Tumor | Phase 1 | 2023-08-16 |
| Unknown | Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2023-07-10 |
| Unknown | A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma Relapsed or Refractory Multiple Myeloma | Phase 1 | 2023-06-30 |
| Unknown | Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-06-30 |
| Completed | Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects Atopic Dermatitis | Phase 1 | 2023-06-25 |
| Recruiting | Study of MHB088C for Patients With Advanced Solid Malignant Tumors Advanced/Metastatic Solid Tumors | Phase 1 / Phase 2 | 2023-06-20 |
| Recruiting | A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-05-19 |
| Unknown | Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma Melanoma, Urothelial Carcinoma | Phase 2 | 2023-04-24 |
| Unknown | A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients | Phase 2 / Phase 3 | 2023-04-20 |
| Unknown | A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2023-04-17 |
| Unknown | A Study of Olanzapine in Patients With Acute Agitation Acute Agitation | Phase 3 | 2023-03-28 |
| Recruiting | A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLS31903 in Advanced Solid Tumo Advanced Solid Tumors | Phase 1 | 2023-03-22 |
| Unknown | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 COVID-19 | Phase 3 | 2023-03-07 |
| Active Not Recruiting | A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung Cancer Lung Cancer | Phase 3 | 2023-02-15 |
| Unknown | A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Acute Myeloid Leukemia and Myelodysplastic Syndrome | Phase 1 | 2023-02-01 |
| Unknown | A Phase 2 Study to Evaluate the Efficacy and Safety of QLS1128 Orally in Symptomatic Participants With Mild to COVID-19 | Phase 2 | 2022-12-30 |
| Recruiting | A Study of QL1706 Combined With Platinum-containing Chemotherapy in Adjuvant Treatment of Stage II-IIIB Non-sm Carcinoma, Non-Small-Cell Lung | Phase 3 | 2022-12-08 |
| Completed | Lifitegrast Eye Drops in Healthy Subjects：Phase I Study Dry Eye Syndromes | Phase 1 | 2022-12-06 |
| Completed | Evaluating the Efficacy and Safety of QL0911 in the Prevention of Chemotherapy- Induced Thrombocytopenia Chemotherapy-induced Thrombocytopenia | Phase 2 / Phase 3 | 2022-11-08 |
| Unknown | To Evaluate the Efficacy of QLH11811 in Advanced NSCLC Patients With EGFR Mutation Non-small Cell Lung Cancer | Phase 1 | 2022-10-25 |
| Unknown | Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2022-09-30 |
| Unknown | QL1706 Monotherapy or in Combination With Bevacizumab and XELOX as First-line Treatment of Unresectable Advanc Colorectal Carcinoma | Phase 2 | 2022-09-29 |
| Unknown | QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervi METASTATIC CERVICAL CANCER | Phase 3 | 2022-09-23 |
| Unknown | A Study of QLS1128 and in Combination With Ritonavir in Healthy Participants COVID-19 | Phase 1 | 2022-07-03 |
| Unknown | Safety, Tolerability and Pharmacokinetics Study of QLH11906 in Patients With Advanced Solid Tumors Harboring M Advanced Solid Tumors Harboring MAPK Pathway Alterations | Phase 1 | 2022-06-14 |
| Unknown | A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer Non-small-cell Lung Cancer | Phase 2 | 2022-06-01 |
| Unknown | A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 2 / Phase 3 | 2022-05-19 |
| Completed | Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy in Extensive-Stage Small Cell Extensive-stage Small-cell Lung Cancer | Phase 2 | 2022-04-18 |
| Unknown | A Study of QL1706 Plus Lenvatinib in Subjects With Advanced Renal Cell Carcinoma(RCC) Advanced Renal Cell Carcinoma | Phase 1 / Phase 2 | 2022-02-28 |
| Unknown | A Phase II Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Cervical Cancer Cervical Cancer | Phase 2 | 2021-12-21 |
| Unknown | QLF32004 Injection for the Treatment of Patients With Advanced Malignant Tumors Advanced Tumor | Phase 1 | 2021-11-09 |
| Unknown | Study to Investigate the Efficacy and Safety of WX-0593 in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Pat Non-small Cell Lung Cancer | Phase 2 | 2021-10-25 |
| Unknown | A Study of QLS31905 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2021-10-25 |
| Completed | CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma Pancreatic Cancer | Phase 1 / Phase 2 | 2021-10-21 |
| Unknown | A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors Solid Tumor, Lymphoma, Non-Hodgkin | Phase 1 | 2021-10-19 |
| Unknown | Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections Complicated Urinary Tract Infection, Acute Pyelonephritis | Phase 2 | 2021-10-08 |
| Unknown | A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Car Advanced Liver Cancer | Phase 1 / Phase 2 | 2021-07-01 |
| Completed | Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers Healthy Volunteers | Phase 1 | 2021-06-16 |
| Unknown | A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies Advanced Malignant Tumor | Phase 1 | 2021-06-02 |
| Unknown | Safety and Efficacy Study of First-line Treatment With QL1706 Plus Chemotherapy With or Without Bevacizumab in Cervical Cancer | Phase 2 | 2021-05-30 |
| Completed | Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers Neoplasms | N/A | 2021-05-10 |
| Unknown | Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer Non-Muscle Invasive Bladder Cancer | Phase 3 | 2021-03-23 |
| Completed | Evaluating the Efficacy and Safety of QL0911 in Chemotherapy- Induced Thrombocytopenia Chemotherapy-induced Thrombocytopenia | Phase 2 / Phase 3 | 2021-01-15 |
| Unknown | A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors Advanced Solid Tumors | Phase 1 | 2021-01-11 |
| Unknown | A Study of the Efficacy and Safety of Pomalidomide Capsules Combined With Low-Dose Dexamethasone in Subjects W Multiple Myeloma, Recurrent or Refractory | Phase 3 | 2021-01-04 |
| Completed | Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Posi Breast Cancer | Phase 3 | 2020-11-23 |
| Unknown | A Phase 1 Study to Assess the Immunogenicity of QL0605 Compared to US Neulasta in Healthy Subjects Healthy | Phase 1 | 2020-11-06 |
| Completed | Monosialoganglioside in Acute Ischemic Stroke: a Randomized, Blinded and Multicenter Confirmatory Study Acute Ischemic Stroke | Phase 3 | 2020-11-03 |
| Completed | Safety, Tolerability, Pharmacokinetics of Intravenous FL058 and Meropenem in Healthy Subjects(SAD/MAD) Healthy | Phase 1 | 2020-10-08 |
| Terminated | QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer Cervical Cancer | Phase 2 / Phase 3 | 2020-09-23 |
| Unknown | A Phase I Study of QL1604 for Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2020-07-20 |
| Unknown | QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors Advanced Malignant Tumor | Phase 2 | 2020-07-08 |
| Completed | Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subje Healthy | Phase 1 | 2020-07-05 |
| Unknown | A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer. Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 2 / Phase 3 | 2020-07-01 |
| Completed | A Multicenter, Double-blind, Randomized, Parallel-group, Phase III Study of the Efficacy and Safety of QL1701 Breast Cancer | Phase 3 | 2020-04-29 |
| Completed | Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers Healthy | Phase 1 | 2020-04-15 |
| Unknown | A Study of QL1706 in Subjects With Advanced Malignant Tumor Advanced Malignant Tumor | Phase 1 | 2020-03-31 |
| Unknown | QL1203 In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy and Safety Metastatic Colorectal Cancer | Phase 3 | 2020-01-20 |
| Completed | Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subje Healthy | Phase 1 | 2019-12-08 |
| Unknown | Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Prolia® in Healthy Adults Healthy People | Phase 1 | 2019-10-31 |
| Unknown | Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. Healthy Males | Phase 1 | 2019-10-28 |
| Completed | Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia Primary Immune Thrombocytopenia | Phase 3 | 2019-10-18 |
| Completed | A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD) Wet Age-related Macular Degeneration | Phase 3 | 2019-08-19 |
| Unknown | An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patie Chronic Hepatitis b | Phase 2 | 2019-07-26 |
| Unknown | An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients Wit Chronic Hepatitis b | Phase 2 | 2019-07-26 |
| Unknown | Efficacy and Safety of QL1206 in the Treatment of Postmenopausal Osteoporosis With High Fracture Risk Postmenopausal Osteoporosis | Phase 3 | 2019-06-05 |
| Unknown | Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients Non-small Cell Lung Cancer | Phase 3 | 2019-06-01 |
| Unknown | A Phase I Study of QL1604 in Subjects With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2019-05-29 |
| Unknown | To Evaluate the Efficacy and Safety of QL1206 and Xgeva in Patients With Bone Metastases From Solid Tumors Bone Metastases | Phase 3 | 2019-04-26 |
| Unknown | A Study Evaluates the Safety and Efficacy of WX-0593 in ALK -Positive, or ROS1-positive Non-small Cell Lung Ca Non-small Cell Lung Cancer | Phase 2 | 2019-03-07 |
| Completed | Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fasted Healthy Volunteers Healthy Volunteers | N/A | 2018-12-28 |
| Completed | Bioequivalence Study of Montelukast Sodium Oral Thin Film and Chewable Tablet in Fed Healthy Volunteers Healthy Volunteers | N/A | 2018-11-27 |
| Completed | Efficacy and Safety of QL1012 in Women for Assisted Reproductive Treatment Infertility | Phase 3 | 2018-10-31 |
| Unknown | A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients Chronic Hepatitis b | Phase 1 | 2018-10-16 |
| Completed | Comparing of the Pharmacokinetic, Safety and Pharmacodynamic of QL1206 and Xgeva® in Healthy Adults Healthy People | Phase 1 | 2018-08-20 |
| Unknown | Gefitinib Combine Radiotherapy as Therapy for Patients With NSCLC Harbouring Sensitive Mutations of EGFR Lung Cancer | N/A | 2018-06-01 |
| Unknown | A Bioequivalence Study of Capecitabine Tablets 500 mg in Adult Cancer Patients Under Fed Condition Colon Cancer, Breast Cancer | Phase 1 | 2018-05-01 |
| Completed | A Bioequivalence Study of Isosorbide-5-Mononitrate Extended-Release Tablets Under Fed Conditions in Healthy Su Bioequivalence | Phase 1 | 2018-04-17 |
| Completed | Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet A Wet Age-related Macular Degeneration | Phase 1 | 2017-12-20 |
| Unknown | Gefitinib With Chemotherapy or Anti-angiogenesis in NSCLC Patients With Bim Deletion or Low EGFR Mutation Abun Non-small-cell Lung Cancer | Phase 2 | 2017-10-12 |
| Unknown | A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients Advanced Solid Tumor, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2017-09-14 |
| Unknown | A Study to Investigate the Safety, Efficacy and Pharmacokinetic Profile of Multiple Doses of QL-007 in Chronic Chronic Hepatitis b | Phase 1 | 2017-08-20 |
| Completed | Efficacy and Safety of QL1101 and Avastin® Respectively Combined With Paclitaxel and Carboplatin in the First- Non-squamous Non-small Cell Lung Cancer | Phase 3 | 2017-03-28 |
| Unknown | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes i Non Small Cell Lung Cancer | — | 2017-03-01 |
| Unknown | A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer Advanced Breast Cancer | Phase 1 | 2013-04-01 |